These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32748838)

  • 1. Quercetin-Resveratrol Combination for Prostate Cancer Management in TRAMP Mice.
    Singh CK; Chhabra G; Ndiaye MA; Siddiqui IA; Panackal JE; Mintie CA; Ahmad N
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32748838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways.
    Ward AB; Mir H; Kapur N; Gales DN; Carriere PP; Singh S
    World J Surg Oncol; 2018 Jun; 16(1):108. PubMed ID: 29898731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular targets for green tea in prostate cancer prevention.
    Adhami VM; Ahmad N; Mukhtar H
    J Nutr; 2003 Jul; 133(7 Suppl):2417S-2424S. PubMed ID: 12840218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP).
    da Silva RF; Nogueira-Pangrazi E; Kido LA; Montico F; Arana S; Kumar D; Raina K; Agarwal R; Cagnon VHA
    J Biomed Sci; 2017 May; 24(1):31. PubMed ID: 28499383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Carotene Oxygenase 2 Genotype Modulates the Impact of Dietary Lycopene on Gene Expression during Early TRAMP Prostate Carcinogenesis.
    Moran NE; Thomas-Ahner JM; Smith JW; Silva C; Hason NA; Erdman JW; Clinton SK
    J Nutr; 2022 Apr; 152(4):950-960. PubMed ID: 34964896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol inhibits DHT-induced progression of prostate cancer cell line through interfering with the AR and CXCR4 pathway.
    Jang YG; Go RE; Hwang KA; Choi KC
    J Steroid Biochem Mol Biol; 2019 Sep; 192():105406. PubMed ID: 31185279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.
    Marques RB; Aghai A; de Ridder CMA; Stuurman D; Hoeben S; Boer A; Ellston RP; Barry ST; Davies BR; Trapman J; van Weerden WM
    Eur Urol; 2015 Jun; 67(6):1177-1185. PubMed ID: 25220373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host versus cell-dependent effects of β-arrestin 1 expression in prostate tumorigenesis.
    Adekoya TO; Smith N; Thomas AJ; Lane TS; Burnette N; Rivers EJ; Li Y; Chen XL; Richardson RM
    Carcinogenesis; 2021 May; 42(5):772-783. PubMed ID: 33710266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol regulates the PTEN/AKT pathway through androgen receptor-dependent and -independent mechanisms in prostate cancer cell lines.
    Wang Y; Romigh T; He X; Orloff MS; Silverman RH; Heston WD; Eng C
    Hum Mol Genet; 2010 Nov; 19(22):4319-29. PubMed ID: 20729295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxm1 expression in prostate epithelial cells is essential for prostate carcinogenesis.
    Cai Y; Balli D; Ustiyan V; Fulford L; Hiller A; Misetic V; Zhang Y; Paluch AM; Waltz SE; Kasper S; Kalin TV
    J Biol Chem; 2013 Aug; 288(31):22527-41. PubMed ID: 23775078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced inhibition of prostate cancer xenograft tumor growth by combining quercetin and green tea.
    Wang P; Vadgama JV; Said JW; Magyar CE; Doan N; Heber D; Henning SM
    J Nutr Biochem; 2014 Jan; 25(1):73-80. PubMed ID: 24314868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) model: A good alternative to study PCa progression and chemoprevention approaches.
    Kido LA; de Almeida Lamas C; Maróstica MR; Cagnon VHA
    Life Sci; 2019 Jan; 217():141-147. PubMed ID: 30528182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of p21/Cdkn1a confers protective effect against prostate tumorigenesis in transgenic adenocarcinoma of the mouse prostate model.
    Jain AK; Raina K; Agarwal R
    Cell Cycle; 2013 May; 12(10):1598-604. PubMed ID: 23624841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylome, transcriptome, and prostate cancer prevention by phenethyl isothiocyanate in TRAMP mice.
    Wu R; Li S; Sargsyan D; Yin R; Kuo HC; Peter R; Wang L; Hudlikar R; Liu X; Kong AN
    Mol Carcinog; 2021 Jun; 60(6):391-402. PubMed ID: 33848375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma.
    Hafeez BB; Zhong W; Weichert J; Dreckschmidt NE; Jamal MS; Verma AK
    Cancer Res; 2011 Mar; 71(6):2318-27. PubMed ID: 21406403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice.
    Hao Q; Henning SM; Magyar CE; Said J; Zhong J; Rettig MB; Vadgama JV; Wang P
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulation of FoxO3a accelerates prostate cancer progression in TRAMP mice.
    Shukla S; Bhaskaran N; Maclennan GT; Gupta S
    Prostate; 2013 Oct; 73(14):1507-17. PubMed ID: 23765843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Resveratrol and Quercetin Causes Cell Growth Inhibition, DNA Damage, Cell Cycle Arrest, and Apoptosis in Oral Cancer Cells.
    Singh V; Singh R; Kujur PK; Singh RP
    Assay Drug Dev Technol; 2020 Jul; 18(5):226-238. PubMed ID: 32423320
    [No Abstract]   [Full Text] [Related]  

  • 19. Liposome encapsulation of curcumin and resveratrol in combination reduces prostate cancer incidence in PTEN knockout mice.
    Narayanan NK; Nargi D; Randolph C; Narayanan BA
    Int J Cancer; 2009 Jul; 125(1):1-8. PubMed ID: 19326431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
    Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
    Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.